Therapeutic Alliance in Interpreter-Mediated Psychotherapy from the Perspective of Refugee Patients: Results of Qualitative Interviews

被引:2
|
作者
Hanft-Robert, Saskia [1 ]
Pohontsch, Nadine Janis [2 ]
Uhr, Cornelia [3 ]
Redlich, Alexander [4 ]
Metzner, Franka [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Gen Practice & Primary Care, Hamburg, Germany
[3] Psychiat Inst Outpatient Clin, Asklepios Clin North Ochsenzoll, Hamburg, Germany
[4] Univ Hamburg, Fac Psychol & Human Movement Sci, Inst Psychol, Hamburg, Germany
关键词
Trust; Interpreter; Psychotherapy; Refugees; Therapeutic alliance; HEALTH-CARE; WORK; EXPERIENCES; TRANSLATION; CHALLENGES; LOST;
D O I
10.1159/000517136
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: The therapeutic alliance is considered to be one of the most important factors of psychotherapy and is a necessary requirement for a successful treatment in interpreter-mediated psychotherapy. Patients and Methods: Using interpreter-mediated guided interviews, 10 refugee patients who experienced interpreter-mediated psychotherapy were asked about factors influencing the development of a trusting therapeutic alliance in the triad. The analysis of the interviews followed the rules of content-structuring qualitative content analysis. Results: A total of 11 factors were identified which could be assigned to the interpreter, therapist, or patient. In the analysis, the central role of the interpreter in establishing a therapeutic alliance in the triad became particularly clear. Conclusions: Consideration of the factors that, from the patients' perspective, influence the establishment and maintenance of a trusting alliance within the triad, as well as the recommendations for action derived from this for psychotherapists and interpreters can lead to an improvement in the therapeutic treatment of refugees.
引用
收藏
页码:190 / 198
页数:9
相关论文
共 31 条
  • [31] Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study
    Adams, David
    Gonzalez-Duarte, Alejandra
    O'Riordan, William
    Yang, Chih-Chao
    Yamashita, Taro
    Kristen, Arnt
    Tournev, Ivaylo
    Schmidt, Hartmut
    Coelho, Teresa
    Berk, John L.
    Lin, Kong-Ping
    Dyck, Peter J.
    Gandhi, Pritesh
    Sweetser, Marianne
    Chen, Jihong
    Goyal, Sunita
    Gollob, Jared
    Suhr, Ole
    NEUROLOGY, 2018, 90